ACR 2025: Autoimmune Post-Conference Report

ACR Convergence 2025 delivered a high volume of new activity across autoimmune R&D. Our analyst team reviewed all 157 autoimmune-relevant abstracts presented at the meeting and synthesized the key clinical, preclinical, and mechanistic trends into one concise Post-Conference Report. Powered by the Beacon Autoimmune database, this report highlights the programs, pathways, and competitors shaping the 2025–2026 landscape.

Your Clear Overview of Trends in Autoimmune R&D

What’s Inside the Report?

Inside, you’ll find everything you need to quickly understand the key autoimmune developments presented at ACR 2025:

  • A complete breakdown of 157 autoimmune abstracts, clearly organized across clinical, preclinical, and trial outline categories
  • Concise visuals summarizing phase distribution across 113 unique clinical trials
  • An overview of the most frequently investigated drugs, including why adalimumab appeared so prominently
  • High-value summaries of clinical, preclinical, and early-stage activity across multiple autoimmune indications
  • Analyst-curated insights that highlight emerging mechanisms, important trial movements, and areas of intensified research focus

Whether you’re monitoring competitor activity, identifying scientific signals, supporting BD and CI strategy, or simply catching up on the meeting, this report gives you the essential takeaways from ACR, without the heavy lift of reviewing every abstract yourself.

ACR

You May Also Be Interested In…

Learn More About Autoimmune

What is Beacon Autoimmune?
  • The Most Comprehensive Way to Search the Autoimmune Drug Development Landscape: Unique search ontologies based on Autoimmune drug and trial characteristics
  • Market Leading Approach to Autoimmune Preclinical & Clinical Data Curation: Manual curation of key Autoimmune research and development data points by Autoimmune research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Autoimmune company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Autoimmune

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search